Disease-Associated Changes in the Striosome and Matrix Compartments of the Dorsal Striatum

Handbook of Behavioral Neuroscience

Volumn 24, Issue , 2016, Pages 783-802

  Crittenden, J R ^a   Graybiel, A M ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

acetylcholine; dopamine; drug addiction; dystonia; eating disorders; Huntington's disease; MOR1; mu opioid; Striatum; striosomes

Indexed keywords

EID: 84998611077     PISSN: 15697339     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-802206-1.00039-8     Document Type: Chapter

References (213)

1. Ahmari, S.E., Spellman, T., Douglass, N.L., Kheirbek, M.A., Simpson, H.B., Deisseroth, K., Gordon, J.A., Hen, R., Repeated cortico-striatal stimulation generates persistent OCD-like behavior. Science 340 (2013), 1234–1239.
2. Albin, R.L., Young, A.B., Penney, J.B., The functional anatomy of basal ganglia disorders. Trends Neurosci. 12 (1989), 366–375.
3. Aliane, V., Perez, S., Bohren, Y., Deniau, J.M., Kemel, M.L., Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies. Brain 134 (2011), 110–118.
4. Amemori, K., Amemori, S., Graybiel, A.M., Motivation and affective judgments differentially recruit neurons in the primate dorsolateral prefrontal and anterior cingulate cortex. J. Neurosci. 35 (2015), 1939–1953.
5. Anderson, K.E., Gehl, C.R., Marder, K.S., Beglinger, L.J., Paulsen, J.S., Huntington's Study G, Comorbidities of obsessive and compulsive symptoms in Huntington's disease. J. Nerv. Ment. Dis. 198 (2010), 334–338.
6. Andre, V.M., Cepeda, C., Fisher, Y.E., Huynh, M., Bardakjian, N., Singh, S., Yang, X.W., Levine, M.S., Differential electrophysiological changes in striatal output neurons in Huntington's disease. J. Neurosci. 31 (2011), 1170–1182.
7. Arlotta, P., Molyneaux, B.J., Jabaudon, D., Yoshida, Y., Macklis, J.D., Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum. J. Neurosci. 28 (2008), 622–632.
8. Augood, S.J., Faull, R.L., Emson, P.C., Dopamine D1 and D2 receptor gene expression in the striatum in Huntington's disease. Ann. Neurol. 42 (1997), 215–221.
9. Augood, S.J., Faull, R.L., Love, D.R., Emson, P.C., Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience 72 (1996), 1023–1036.
10. Avena, N.M., Rada, P., Hoebel, B.G., Underweight rats have enhanced dopamine release and blunted acetylcholine response in the nucleus accumbens while bingeing on sucrose. Neuroscience 156 (2008), 865–871.
11. Avena, N.M., Rada, P.V., Cholinergic modulation of food and drug satiety and withdrawal. Physiol. Behav. 106 (2012), 332–336.
12. Aylward, E.H., Harrington, D.L., Mills, J.A., Nopoulos, P.C., Ross, C.A., Long, J.D., Liu, D., Westervelt, H.K., Paulsen, J.S., Investigators, P.-H., Coordinators of the Huntington Study Group, Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. J. Huntingtons Dis. 2 (2013), 477–489.
13. Badiani, A., Oates, M.M., Day, H.E., Watson, S.J., Akil, H., Robinson, T.E., Amphetamine-induced behavior, dopamine release, and c-fos mRNA expression: modulation by environmental novelty. J. Neurosci. 18 (1998), 10579–10593.
14. Belin, D., Everitt, B.J., Cocaine seeking habits depend upon dopamine-dependent serial connectivity linking the ventral with the dorsal striatum. Neuron 57 (2008), 432–441.
15. Belluscio, L., Gold, G.H., Nemes, A., Axel, R., Mice deficient in G(olf) are anosmic. Neuron 20 (1998), 69–81.
16. Benn, C.L., Sun, T., Sadri-Vakili, G., McFarland, K.N., DiRocco, D.P., Yohrling, G.J., Clark, T.W., Bouzou, B., Cha, J.H., Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a polyglutamine-dependent manner. J. Neurosci. 28 (2008), 10720–10733.
17. Berretta, S., Parthasarathy, H.B., Graybiel, A.M., Local release of GABAergic inhibition in the motor cortex induces immediate-early gene expression in indirect pathway neurons of the striatum. J. Neurosci. 17 (1997), 4752–4763.
18. Bertran-Gonzalez, J., Bosch, C., Maroteaux, M., Matamales, M., Herve, D., Valjent, E., Girault, J.A., Opposing patterns of signaling activation in dopamine D1 and D2 receptor-expressing striatal neurons in response to cocaine and haloperidol. J. Neurosci. 28 (2008), 5671–5685.
19. Bickerdike, M.J., Abercrombie, E.D., Striatal acetylcholine release correlates with behavioral sensitization in rats withdrawn from chronic amphetamine. J. Pharmacol. Exp. Ther. 282 (1997), 818–826.
20. Brazhnik, E., Shah, F., Tepper, J.M., GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo. J. Neurosci. 28 (2008), 10386–10398.
21. Breakefield, X.O., Blood, A.J., Li, Y., Hallett, M., Hanson, P.I., Standaert, D.G., The pathophysiological basis of dystonias. Nat. Rev. Neurosci. 9 (2008), 222–234.
22. Bressman, S.B., Dystonia update. Clin. Neuropharmacol. 23 (2000), 239–251.
23. Breuer, O., Lawhorn, C., Miller, T., Smith, D.M., Brown, L.L., Functional architecture of the mammalian striatum: mouse vascular and striosome organization and their anatomic relationships. Neurosci. Lett. 385 (2005), 198–203.
24. Brockmann, K., Episodic movement disorders: from phenotype to genotype and back. Curr. Neurol. Neurosci. Rep., 13, 2013, 379.
25. Burguiere, E., Monteiro, P., Feng, G., Graybiel, A.M., Optogenetic stimulation of lateral orbitofronto-striatal pathway suppresses compulsive behaviors. Science 340 (2013), 1243–1246.
26. Cachope, R., Cheer, J.F., Local control of striatal dopamine release. Front. Behav. Neurosci., 8, 2014, 188.
27. Canales, J.J., Graybiel, A.M., A measure of striatal function predicts motor stereotypy. Nat. Neurosci. 3 (2000), 377–383.
28. Capper-Loup, C., Canales, J.J., Kadaba, N., Graybiel, A.M., Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization. J. Neurosci. 22 (2002), 6218–6227.
29. Charlesworth, G., Bhatia, K.P., Wood, N.W., The genetics of dystonia: new twists in an old tale. Brain 136 (2013), 2017–2037.
30. Chefer, V.I., Czyzyk, T., Bolan, E.A., Moron, J., Pintar, J.E., Shippenberg, T.S., Endogenous kappa-opioid receptor systems regulate mesoaccumbal dopamine dynamics and vulnerability to cocaine. J. Neurosci. 25 (2005), 5029–5037.
31. Clot, F., et al. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain 132 (2009), 1753–1763.
32. Collins, S.L., Izenwasser, S., Chronic nicotine differentially alters cocaine-induced locomotor activity in adolescent vs. adult male and female rats. Neuropharmacology 46 (2004), 349–362.
33. Conforti, P., Camnasio, S., Mutti, C., Valenza, M., Thompson, M., Fossale, E., Zeitlin, S., MacDonald, M.E., Zuccato, C., Cattaneo, E., Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death. Neurobiol. Dis. 50 (2013), 160–170.
34. Corvol, J.C., Muriel, M.P., Valjent, E., Feger, J., Hanoun, N., Girault, J.A., Hirsch, E.C., Herve, D., Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. J. Neurosci. 24 (2004), 7007–7014.
35. Cosgrove, K.P., Veldhuizen, M.G., Sandiego, C.M., Morris, E.D., Small, D.M., Opposing relationships of BMI with BOLD and dopamine D2/3 receptor binding potential in the dorsal striatum. Synapse 69 (2015), 195–202.
36. Crittenden, J.R., Cantuti-Castelvetri, I., Saka, E., Keller-McGandy, C.E., Hernandez, L.F., Kett, L.R., Young, A.B., Standaert, D.G., Graybiel, A.M., Dysregulation of CalDAG-GEFI and CalDAG-GEFII predicts the severity of motor side-effects induced by anti-parkinsonian therapy. Proc. Natl. Acad. Sci. U.S.A. 106 (2009), 2892–2896.
37. Crittenden, J.R., Dunn, D.E., Merali, F.I., Woodman, B., Yim, M., Borkowska, A.E., Frosch, M.P., Bates, G.P., Housman, D.E., Lo, D.C., Graybiel, A.M., CalDAG-GEFI down-regulation in the striatum as a neuroprotective change in Huntington's disease. Hum. Mol. Genet. 19 (2010), 1756–1765.
38. Crittenden, J.R., Graybiel, A.M., Basal Ganglia disorders associated with imbalances in the striatal striosome and matrix compartments. Front. Neuroanat., 5, 2011, 59.
39. Crittenden, J.R., Lacey, C.J., Bowden, H.A., Housman, D.E., Graybiel, A.M., CalDAG-GEFI Resets Neuronal Activity in the Striatum and Controls Repetitive Behaviors. Symposium, 2013, Cajal Institute, Madrid, Spain.
40. Crittenden, J.R., Lacey, C.J., Lee, T., Bowden, H.A., Graybiel, A.M., Severe drug-induced repetitive behaviors and striatal overexpression of VAChT in ChAT-ChR2-EYFP BAC transgenic mice. Front. Neural Circuits, 8, 2014, 57.
41. Crook, Z.R., Housman, D.E., Dysregulation of dopamine receptor D2 as a sensitive measure for Huntington disease pathology in model mice. Proc. Natl. Acad. Sci. U.S.A. 109 (2012), 7487–7492.
42. Cui, Y., Ostlund, S.B., James, A.S., Park, C.S., Ge, W., Roberts, K.W., Mittal, N., Murphy, N.P., Cepeda, C., Kieffer, B.L., Levine, M.S., Jentsch, J.D., Walwyn, W.M., Sun, Y.E., Evans, C.J., Maidment, N.T., Yang, X.W., Targeted expression of mu-opioid receptors in a subset of striatal direct-pathway neurons restores opiate reward. Nat. Neurosci. 17 (2014), 254–261.
43. Damier, P., Hirsch, E.C., Agid, Y., Graybiel, A.M., The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 122:Pt 8 (1999), 1437–1448.
44. Dautan, D.H.-O.I., Witten, I.B., Deisseroth, K., Bolam, J.P., Gerdjikov, T., Mena-Segovia, J., A Major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem. J. Neurosci. 34 (2014), 4509–4518.
45. Davis, M.I., Puhl, H.L. III, Nr4a1-eGFP is a marker of striosome–matrix architecture, development and activity in the extended striatum. PLoS One, 6, 2011, e16619.
46. Deng, Y.P., Wong, T., Wan, J.Y., Reiner, A., Differential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease. Front. Syst. Neurosci., 8, 2014, 198.
47. Denys, D., de Vries, F., Cath, D., Figee, M., Vulink, N., Veltman, D.J., van der Doef, T.F., Boellaard, R., Westenberg, H., van Balkom, A., Lammertsma, A.A., van Berckel, B.N., Dopaminergic activity in Tourette syndrome and obsessive–compulsive disorder. Eur. Neuropsychopharmacol. 23 (2013), 1423–1431.
48. Desplats, P.A., Kass, K.E., Gilmartin, T., Stanwood, G.D., Woodward, E.L., Head, S.R., Sutcliffe, J.G., Thomas, E.A., Selective deficits in the expression of striatal-enriched mRNAs in Huntington's disease. J. Neurochem. 96 (2006), 743–757.
49. DiFeliceantonio, A.G., Mabrouk, O.S., Kennedy, R.T., Berridge, K.C., Enkephalin surges in dorsal neostriatum as a signal to eat. Curr. Biol. 22 (2012), 1918–1924.
50. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P., Aronin, N., Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997), 1990–1993.
51. Domingo, A., Westenberger, A., Lee, L.V., Braenne, I., Liu, T., Vater, I., Rosales, R., Jamora, R.D., Pasco, P.M., Cutiongco-Dela Paz, E.M., Freimann, K., Schmidt, T.G., Dressler, D., Kaiser, F.J., Bertram, L., Erdmann, J., Lohmann, K., Klein, C., New insights into the genetics of X-linked dystonia–parkinsonism (XDP, DYT3). Eur. J. Hum. Genet. 23 (2015), 1334–1340.
52. Eblen, F., Graybiel, A.M., Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. J. Neurosci. 15 (1995), 5999–6013.
53. Everitt, B.J., Robbins, T.W., From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 37 (2013), 1946–1954.
54. Fentress, J.C., Stanfield, B.B., Cowan, W.M., Observation on the development of the striatum in mice and rats. Anat. Embryol. 163 (1981), 275–298.
55. Ferguson, S.M., Norton, C.S., Watson, S.J., Akil, H., Robinson, T.E., Amphetamine-evoked c-fos mRNA expression in the caudate–putamen: the effects of DA and NMDA receptor antagonists vary as a function of neuronal phenotype and environmental context. J. Neurochem. 86 (2003), 33–44.
56. Ferguson, S.M., Phillips, P.E., Roth, B.L., Wess, J., Neumaier, J.F., Direct-pathway striatal neurons regulate the retention of decision-making strategies. J. Neurosci. 33 (2013), 11668–11676.
57. Ferrante, R.J., Kowall, N.W., Beal, M.F., Martin, J.B., Bird, E.D., Richardson, E.P. Jr., Morphologic and histochemical characteristics of a spared subset of striatal neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 46 (1987), 12–27.
58. Flagel, S.B., Clark, J.J., Robinson, T.E., Mayo, L., Czuj, A., Willuhn, I., Akers, C.A., Clinton, S.M., Phillips, P.E., Akil, H., A selective role for dopamine in stimulus-reward learning. Nature 469 (2011), 53–57.
59. Flaherty, A.W., Graybiel, A.M., Motor and somatosensory corticostriatal projection magnifications in the squirrel monkey. J. Neurophysiol. 74 (1995), 2638–2648.
60. Francelle, L., Galvan, L., Brouillet, E., Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease. Front. Cell Neurosci., 8, 2014, 295.
61. Frank, G.K., Bailer, U.F., Henry, S.E., Drevets, W., Meltzer, C.C., Price, J.C., Mathis, C.A., Wagner, A., Hoge, J., Ziolko, S., Barbarich-Marsteller, N., Weissfeld, L., Kaye, W.H., Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol. Psychiatry 58 (2005), 908–912.
62. Frank, S., Treatment of Huntington's disease. Neurotherapeutics 11 (2014), 153–160.
63. Friedman, A., Homma, D., Gibb, L.G., Amemori, K., Rubin, S.J., Hood, A.S., Riad, M.H., Graybiel, A.M., A corticostriatal path targeting striosomes controls decision-making under conflict. Cell 161 (2015), 1320–1333.
64. Fuchs, T., Saunders-Pullman, R., Masuho, I., Luciano, M.S., Raymond, D., Factor, S., Lang, A.E., Liang, T.W., Trosch, R.M., White, S., Ainehsazan, E., Herve, D., Sharma, N., Ehrlich, M.E., Martemyanov, K.A., Bressman, S.B., Ozelius, L.J., Mutations in GNAL cause primary torsion dystonia. Nat. Genet. 45 (2013), 88–92.
65. Fujiyama, F., Sohn, J., Nakano, T., Furuta, T., Nakamura, K.C., Matsuda, W., Kaneko, T., Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur. J. Neurosci. 33 (2011), 668–677.
66. Fujiyama, F., Takahashi, S., Karube, F., Morphological elucidation of basal ganglia circuits contributing reward prediction. Front. Neurosci., 9, 2015, 6.
67. Fujiyama, F., Unzai, T., Nakamura, K., Nomura, S., Kaneko, T., Difference in organization of corticostriatal and thalamostriatal synapses between patch and matrix compartments of rat neostriatum. Eur. J. Neurosci. 24 (2006), 2813–2824.
68. Gangarossa, G., Espallergues, J., Mailly, P., De Bundel, D., de Kerchove d'Exaerde, A., Herve, D., Girault, J.A., Valjent, E., Krieger, P., Spatial distribution of D1R- and D2R-expressing medium-sized spiny neurons differs along the rostro-caudal axis of the mouse dorsal striatum. Front. Neural Circuits, 7, 2013, 124.
69. Gerfen, C.R., The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311 (1984), 461–464.
70. Gerfen, C.R., Herkenham, M., Thibault, J., The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J. Neurosci. 7 (1987), 3915–3934.
71. Giuliano, C., Robbins, T.W., Nathan, P.J., Bullmore, E.T., Everitt, B.J., Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology 37 (2012), 2643–2652.
72. Giuliano, C., Robbins, T.W., Wille, D.R., Bullmore, E.T., Everitt, B.J., Attenuation of cocaine and heroin seeking by mu-opioid receptor antagonism. Psychopharmacology (Berl.) 227 (2013), 137–147.
73. Glass, M., Dragunow, M., Faull, R.L., The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease. Neuroscience 97 (2000), 505–519.
74. Glickstein, S.B., Schmauss, C., Focused motor stereotypies do not require enhanced activation of neurons in striosomes. J. Comp. Neurol. 469 (2004), 227–238.
75. Gorelick, D.A., Kim, Y.K., Bencherif, B., Boyd, S.J., Nelson, R., Copersino, M., Endres, C.J., Dannals, R.F., Frost, J.J., Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Biol. Psychiatry 57 (2005), 1573–1582.
76. Goto, S., Lee, L.V., Munoz, E.L., Tooyama, I., Tamiya, G., Makino, S., Ando, S., Dantes, M.B., Yamada, K., Matsumoto, S., Shimazu, H., Kuratsu, J., Hirano, A., Kaji, R., Functional anatomy of the basal ganglia in X-linked recessive dystonia–parkinsonism. Ann. Neurol. 58 (2005), 7–17.
77. Gray, M.A., Egan, G.F., Ando, A., Churchyard, A., Chua, P., Stout, J.C., Georgiou-Karistianis, N., Prefrontal activity in Huntington's disease reflects cognitive and neuropsychiatric disturbances: the IMAGE-HD study. Exp. Neurol. 239 (2013), 218–228.
78. Graybiel A.M., 1984. Correspondence between the dopamine islands and striosomes of the mammalian striatum. Neuroscience 13:1157–1187.
79. Graybiel, A.M., Habits, rituals, and the evaluative brain. Annual Review of Neuroscience 31 (2008), 359–387.
80. Graybiel, A.M., Baughman, R.W., Eckenstein, F., Cholinergic neuropil of the striatum observes striosomal boundaries. Nature 323 (1986), 625–627.
81. Graybiel, A.M., Canales, J.J., Capper-Loup, C., Levodopa-induced dyskinesias and dopamine-dependent stereotypies: a new hypothesis. Trends Neurosci. 23 (2000), S71–77.
82. Graybiel, A.M., Hickey, T.L., Chemospecificity of ontogenetic units in the striatum: demonstration by combining [3H]thymidine neuronography and histochemical staining. Proc. Natl. Acad. Sci. U.S.A. 79 (1982), 198–202.
83. Graybiel, A.M., Hirsch, E.C., Agid, Y.A., Differences in tyrosine hydroxylase-like immunoreactivity characterize the mesostriatal innervation of striosomes and extrastriosomal matrix at maturity. Proc. Natl. Acad. Sci. U.S.A. 84 (1987), 303–307.
84. Graybiel, A.M., Moratalla, R., Dopamine uptake sites in the striatum are distributed differentially in striosome and matrix compartments. Proc. Natl. Acad. Sci. U.S.A. 86 (1989), 9020–9024.
85. Graybiel, A.M., Moratalla, R., Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome–matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A. 87 (1990), 6912–6916.
86. Graybiel, A.M., Pickel, V.M., Joh, T.H., Reis, D.J., Ragsdale, C.W. Jr., Direct demonstration of a correspondence between the dopamine islands and acetylcholinesterase patches in the developing striatum. Proc. Natl. Acad. Sci. U.S.A. 78 (1981), 5871–5875.
87. Graybiel, A.M., Ragsdale, C.W. Jr., Histochemically distinct compartments in the striatum of human, monkeys, and cat demonstrated by acetylthiocholinesterase staining. Proc. Natl. Acad. Sci. U.S.A. 75 (1978), 5723–5726.
88. Graybiel, A.M., Ragsdale, C.W. Jr., Clumping of acetylcholinesterase activity in the developing striatum of the human fetus and young infant. Proc. Natl. Acad. Sci. U.S.A. 77 (1980), 1214–1218.
89. Graybiel, A.M., Rauch, S.L., Toward a neurobiology of obsessive–compulsive disorder. Neuron 28 (2000), 343–347.
90. Groen, J.L., Ritz, K., Warner, T.T., Baas, F., Tijssen, M.A., DRD1 rare variants associated with tardive-like dystonia: a pilot pathway sequencing study in dystonia. Parkinsonism Relat. Disord. 20 (2014), 782–785.
91. Haber, S.N., Fudge, J.L., McFarland, N.R., Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J. Neurosci. 20 (2000), 2369–2382.
92. Hallett, M., Neurophysiology of dystonia: the role of inhibition. Neurobiol. Dis. 42 (2011), 177–184.
93. Han, I., You, Y., Kordower, J.H., Brady, S.T., Morfini, G.A., Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. J. Neurochem. 113 (2010), 1073–1091.
94. Hansen, F.H., et al. Missense dopamine transporter mutations associate with adult parkinsonism and ADHD. The J. Clin. Investig. 124 (2014), 3107–3120.
95. Harrington, D.L., Liu, D., Smith, M.M., Mills, J.A., Long, J.D., Aylward, E.H., Paulsen, J.S., Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease. Brain Behav. 4 (2014), 29–40.
96. Hedreen, J.C., Folstein, S.E., Early loss of neostriatal striosome neurons in Huntington's disease. J. Neuropathol. Exp. Neurol. 54 (1995), 105–120.
97. Henry, B., Duty, S., Fox, S.H., Crossman, A.R., Brotchie, J.M., Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease. Exp. Neurol. 183 (2003), 458–468.
98. Herve, D., Identification of a specific assembly of the g protein golf as a critical and regulated module of dopamine and adenosine-activated cAMP pathways in the striatum. Front. Neuroanat., 5, 2011, 48.
99. Homma, D., Katoh, S., Tokuoka, H., Ichinose, H., The role of tetrahydrobiopterin and catecholamines in the developmental regulation of tyrosine hydroxylase level in the brain. J. Neurochem. 126 (2013), 70–81.
100. Homma, D., Sumi-Ichinose, C., Tokuoka, H., Ikemoto, K., Nomura, T., Kondo, K., Katoh, S., Ichinose, H., Partial biopterin deficiency disturbs postnatal development of the dopaminergic system in the brain. J. Biol. Chem. 286 (2011), 1445–1452.
101. Horner, K.A., Hebbard, J.C., Logan, A.S., Vanchipurakel, G.A., Gilbert, Y.E., Activation of mu opioid receptors in the striatum differentially augments methamphetamine-induced gene expression and enhances stereotypic behavior. J. Neurochem. 120 (2012), 779–794.
102. Huang, B., Wei, W., Wang, G., Gaertig, M.A., Feng, Y., Wang, W., Li, X.J., Li, S., Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes. Neuron 85 (2015), 1212–1226.
103. Huntington Study Group, Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66 (2006), 366–372.
104. Hurd, Y.L., Herkenham, M., Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13 (1993), 357–369.
105. Ichinose, H., Ohye, T., Takahashi, E., Seki, N., Hori, T., Segawa, M., Nomura, Y., Endo, K., Tanaka, H., Tsuji, S., Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 8 (1994), 236–242.
106. Ikemoto, S., Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens–olfactory tubercle complex. Brain Res. Rev. 56 (2007), 27–78.
107. Jabourian, M., Venance, L., Bourgoin, S., Ozon, S., Perez, S., Godeheu, G., Glowinski, J., Kemel, M.L., Functional mu opioid receptors are expressed in cholinergic interneurons of the rat dorsal striatum: territorial specificity and diurnal variation. Eur. J. Neurosci. 21 (2005), 3301–3309.
108. Jacobsen, J.C., Bawden, C.S., Rudiger, S.R., McLaughlan, C.J., Reid, S.J., Waldvogel, H.J., MacDonald, M.E., Gusella, J.F., Walker, S.K., Kelly, J.M., Webb, G.C., Faull, R.L., Rees, M.I., Snell, R.G., An ovine transgenic Huntington's disease model. Hum. Mol. Genet. 19 (2010), 1873–1882.
109. Janis, L.S., Cassidy, R.M., Kromer, L.F., Ephrin-A binding and EphA receptor expression delineate the matrix compartment of the striatum. J. Neurosci. 19 (1999), 4962–4971.
110. Jedynak, J.P., Cameron, C.M., Robinson, T.E., Repeated methamphetamine administration differentially alters fos expression in caudate–putamen patch and matrix compartments and nucleus accumbens. PloS One, 7, 2012, e34227.
111. Jimenez-Castellanos, J., Graybiel, A.M., Evidence that histochemically distinct zones of the primate substantia nigra pars compacta are related to patterned distributions of nigrostriatal projection neurons and striatonigral fibers. Exp. Brain Res. 74 (1989), 227–238.
112. Kaji, R., Urushihara, R., Murase, N., Shimazu, H., Goto, S., Abnormal sensory gating in basal ganglia disorders. J. Neurol. 252:Suppl. 4 (2005), IV13–IV16.
113. Karlsson, H.K., Tuominen, L., Tuulari, J.J., Hirvonen, J., Parkkola, R., Helin, S., Salminen, P., Nuutila, P., Nummenmaa, L., Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain. J. Neurosci. 35 (2015), 3959–3965.
114. Kelley, A.E., Gauthier, A.M., Lang, C.G., Amphetamine microinjections into distinct striatal subregions cause dissociable effects on motor and ingestive behavior. Behav. Brain Res. 35 (1989), 27–39.
115. Kelley, A.E., Will, M.J., Steininger, T.L., Zhang, M., Haber, S.N., Restricted daily consumption of a highly palatable food (chocolate Ensure(R)) alters striatal enkephalin gene expression. Eur. J. Neurosci. 18 (2003), 2592–2598.
116. Kincaid, A.E., Wilson, C.J., Corticostriatal innervation of the patch and matrix in the rat neostriatum. J. Comp. Neurol. 374 (1996), 578–592.
117. Kravitz, A.V., Freeze, B.S., Parker, P.R., Kay, K., Thwin, M.T., Deisseroth, K., Kreitzer, A.C., Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 466 (2010), 622–626.
118. Kuczenski, R., Segal, D.S., Caudate–putamen and nucleus accumbens extracellular acetylcholine responses to methamphetamine binges. Brain Res. 923 (2001), 32–38.
119. Kuhn, A., et al. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage. Hum. Mol. Genet. 16 (2007), 1845–1861.
120. Kurian, M.A., Zhen, J., Cheng, S.Y., Li, Y., Mordekar, S.R., Jardine, P., Morgan, N.V., Meyer, E., Tee, L., Pasha, S., Wassmer, E., Heales, S.J., Gissen, P., Reith, M.E., Maher, E.R., Homozygous loss-of-function mutations in the gene encoding the dopamine transporter are associated with infantile parkinsonism–dystonia. The J. Clin. Investig. 119 (2009), 1595–1603.
121. Langer, L.F., Graybiel, A.M., Distinct nigrostriatal projection systems innervate striosomes and matrix in the primate striatum. Brain Res. 498 (1989), 344–350.
122. Lawhorn, C., Smith, D.M., Brown, L.L., Striosome–matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease. Neurobiol. Dis. 32 (2008), 471–478.
123. Lawhorn, C., Smith, D.M., Brown, L.L., Partial ablation of mu-opioid receptor rich striosomes produces deficits on a motor-skill learning task. Neuroscience 163 (2009), 109–119.
124. Lawrence, A.D., Sahakian, B.J., Hodges, J.R., Rosser, A.E., Lange, K.W., Robbins, T.W., Executive and mnemonic functions in early Huntington's disease. Brain 119:Pt 5 (1996), 1633–1645.
125. Lee, H., Leamey, C.A., Sawatari, A., Rapid reversal of chondroitin sulfate proteoglycan associated staining in subcompartments of mouse neostriatum during the emergence of behaviour. PloS One, 3, 2008, e3020.
126. Lee, J.M., et al. CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology 78 (2012), 690–695.
127. Lee, W.C., Yoshihara, M., Littleton, J.T., Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 3224–3229.
128. Liao, W.L., Tsai, H.C., Wang, H.F., Chang, J., Lu, K.M., Wu, H.L., Lee, Y.C., Tsai, T.F., Takahashi, H., Wagner, M., Ghyselinck, N.B., Chambon, P., Liu, F.C., Modular patterning of structure and function of the striatum by retinoid receptor signaling. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 6765–6770.
129. Lopez-Huerta, V.G., Nakano, Y., Bausenwein, J., Jaidar, O., Lazarus, M., Cherassse, Y., Garcia-Munoz, M., Arbuthnott, G., The neostriatum: two entities, one structure?. Brain Struct. Funct. 221 (2015), 1737–1749.
130. Ludecke, B., Knappskog, P.M., Clayton, P.T., Surtees, R.A., Clelland, J.D., Heales, S.J., Brand, M.P., Bartholome, K., Flatmark, T., Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 5 (1996), 1023–1028.
131. Makino, S., Kaji, R., Ando, S., Tomizawa, M., Yasuno, K., Goto, S., Matsumoto, S., Tabuena, M.D., Maranon, E., Dantes, M., Lee, L.V., Ogasawara, K., Tooyama, I., Akatsu, H., Nishimura, M., Tamiya, G., Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia–parkinsonism. Am. J. Hum. Genet. 80 (2007), 393–406.
132. Martin, L.J., Cork, L.C., The non-human primate striatum undergoes marked prolonged remodeling during postnatal development. Front. Cell Neurosci., 8, 2014, 294.
133. Matsuda, W., Furuta, T., Nakamura, K.C., Hioki, H., Fujiyama, F., Arai, R., Kaneko, T., Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J. Neurosci. 29 (2009), 444–453.
134. McKinstry, S.U., Karadeniz, Y.B., Worthington, A.K., Hayrapetyan, V.Y., Ozlu, M.I., Serafin-Molina, K., Risher, W.C., Ustunkaya, T., Dragatsis, I., Zeitlin, S., Yin, H.H., Eroglu, C., Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits. J. Neurosci. 34 (2014), 9455–9472.
135. Menalled, L.B., Sison, J.D., Wu, Y., Olivieri, M., Li, X.J., Li, H., Zeitlin, S., Chesselet, M.F., Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice. J. Neurosci. 22 (2002), 8266–8276.
136. Mink, J.W., The Basal ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch. Neurol. 60 (2003), 1365–1368.
137. Miura, M., Saino-Saito, S., Masuda, M., Kobayashi, K., Aosaki, T., Compartment-specific modulation of GABAergic synaptic transmission by mu-opioid receptor in the mouse striatum with green fluorescent protein-expressing dopamine islands. J. Neurosci. 27 (2007), 9721–9728.
138. Morigaki, R., Nakataki, M., Kawarai, T., Lee, L.V., Teleg, R.A., Tabuena, M.D., Mure, H., Sako, W., Pasco, P.M., Nagahiro, S., Iga, J., Ohmori, T., Goto, S., Kaji, R., Depression in X-linked dystonia–parkinsonism: a case–control study. Parkinsonism Relat. Disord. 19 (2013), 844–846.
139. Morton, A.J., Nicholson, L.F., Faull, R.L., Compartmental loss of NADPH diaphorase in the neuropil of the human striatum in Huntington's disease. Neuroscience 53 (1993), 159–168.
140. Murray, R.C., Gilbert, Y.E., Logan, A.S., Hebbard, J.C., Horner, K.A., Striatal patch compartment lesions alter methamphetamine-induced behavior and immediate early gene expression in the striatum, substantia nigra and frontal cortex. Brain Struct. Funct. 219 (2014), 1213–1229.
141. Nakamura, K.C., Fujiyama, F., Furuta, T., Hioki, H., Kaneko, T., Afferent islands are larger than mu-opioid receptor patch in striatum of rat pups. NeuroReport 20 (2009), 584–588.
142. Nelson, D.L., Orr, H.T., Warren, S.T., The unstable repeats—three evolving faces of neurological disease. Neuron 77 (2013), 825–843.
143. Newman, H., Liu, F.C., Graybiel, A.M., Dynamic ordering of early generated striatal cells destined to form the striosomal compartment of the striatum. J. Comp. Neurol. 523 (2015), 943–962.
144. Newman-Gage, H., Graybiel, A.M., Expression of calcium/calmodulin-dependent protein kinase in relation to dopamine islands and synaptic maturation in the cat striatum. J. Neurosci. 8 (1988), 3360–3375.
145. Ng, J., et al. Dopamine transporter deficiency syndrome: phenotypic spectrum from infancy to adulthood. Brain 137 (2014), 1107–1119.
146. Nguyen, X.V., Liu, M., Kim, H.C., Bing, G., Effects of prodynorphin deletion on striatal dopamine in mice during normal aging and in response to MPTP. Exp. Neurol. 219 (2009), 228–238.
147. Nummenmaa, L., Hirvonen, J., Hannukainen, J.C., Immonen, H., Lindroos, M.M., Salminen, P., Nuutila, P., Dorsal striatum and its limbic connectivity mediate abnormal anticipatory reward processing in obesity. PloS One, 7, 2012, e31089.
148. Ochaba, J., Lukacsovich, T., Csikos, G., Zheng, S., Margulis, J., Salazar, L., Mao, K., Lau, A.L., Yeung, S.Y., Humbert, S., Saudou, F., Klionsky, D.J., Finkbeiner, S., Zeitlin, S.O., Marsh, J.L., Housman, D.E., Thompson, L.M., Steffan, J.S., Potential function for the Huntingtin protein as a scaffold for selective autophagy. Proc. Natl. Acad. Sci. U.S.A. 111 (2014), 16889–16894.
149. O'Rawe, J.A., Wu, Y., Rope, A., Jimenez Barron, L.T., Swensen, J., Fang, H., Mittelman, D., Highnam, G., Robison, R., Yang, E., Wang, K., Lyon, G.J., A variant in TAF1 is associated with a new syndrome with severe intellectual disability and characteristic dysmorphic features. bioRxiv, 2015 (preprint).
150. Pert, C.B., Kuhar, M.J., Snyder, S.H., Opiate receptor: autoradiographic localization in rat brain. Proc. Natl. Acad. Sci. U.S.A. 73 (1976), 3729–3733.
151. Peterson, D.A., Sejnowski, T.J., Poizner, H., Convergent evidence for abnormal striatal synaptic plasticity in dystonia. Neurobiol. Dis. 37 (2010), 558–573.
152. Placzek, M.R., Misbahuddin, A., Chaudhuri, K.R., Wood, N.W., Bhatia, K.P., Warner, T.T., Cervical dystonia is associated with a polymorphism in the dopamine (D5) receptor gene. J. Neurol. Neurosurg. Psychiatry 71 (2001), 262–264.
153. Ponten, H., Kullingsjo, J., Lagerkvist, S., Martin, P., Pettersson, F., Sonesson, C., Waters, S., Waters, N., In vivo pharmacology of the dopaminergic stabilizer pridopidine. Eur. J. Pharmacol. 644 (2010), 88–95.
154. Pouladi, M.A., Graham, R.K., Karasinska, J.M., Xie, Y., Santos, R.D., Petersen, A., Hayden, M.R., Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin. Brain 132 (2009), 919–932.
155. Pratt, W.E., Kelley, A.E., Striatal muscarinic receptor antagonism reduces 24-h food intake in association with decreased preproenkephalin gene expression. Eur. J. Neurosci. 22 (2005), 3229–3240.
156. Prensa, L., Parent, A., The nigrostriatal pathway in the rat: a single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments. J. Neurosci. 21 (2001), 7247–7260.
157. Ragsdale, C.W. Jr., Graybiel, A.M., Fibers from the basolateral nucleus of the amygdala selectively innervate striosomes in the caudate nucleus of the cat. J. Comp. Neurol. 269 (1988), 506–522.
158. Ragsdale, C.W. Jr., Graybiel, A.M., A simple ordering of neocortical areas established by the compartmental organization of their striatal projections. Proc. Natl. Acad. Sci. U.S.A. 87 (1990), 6196–6199.
159. Ragsdale, C.W. Jr., Graybiel, A.M., Compartmental organization of the thalamostriatal connection in the cat. J. Comp. Neurol. 311 (1991), 134–167.
160. Rajakumar, N., Elisevich, K., Flumerfelt, B.A., Compartmental origin of the striato-entopeduncular projection in the rat. J. Comp. Neurol. 331 (1993), 286–296.
161. Rajput, A.H., Gibb, W.R., Zhong, X.H., Shannak, K.S., Kish, S., Chang, L.G., Hornykiewicz, O., Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann. Neurol. 35 (1994), 396–402.
162. Raju, D.V., Shah, D.J., Wright, T.M., Hall, R.A., Smith, Y., Differential synaptology of vGluT2-containing thalamostriatal afferents between the patch and matrix compartments in rats. J. Comp. Neurol. 499 (2006), 231–243.
163. Reiner, A., Albin, R.L., Anderson, K.D., D'Amato, C.J., Penney, J.B., Young, A.B., Differential loss of striatal projection neurons in Huntington disease. Proc. Natl. Acad. Sci. U.S.A. 85 (1988), 5733–5737.
164. Reinius, B., Blunder, M., Brett, F.M., Eriksson, A., Patra, K., Jonsson, J., Jazin, E., Kullander, K., Conditional targeting of medium spiny neurons in the striatal matrix. Front. Behav. Neurosci., 9, 2015, 71.
165. Robinson, M.J., Burghardt, P.R., Patterson, C.M., Nobile, C.W., Akil, H., Watson, S.J., Berridge, K.C., Ferrario, C.R., Individual differences in cue-induced motivation and striatal systems in rats susceptible to diet-induced obesity. Neuropsychopharmacology 40 (2015), 2113–2123.
166. Robinson, T.E., Berridge, K.C., The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Rev. 18 (1993), 247–291.
167. Ross, C.A., Aylward, E.H., Wild, E.J., Langbehn, D.R., Long, J.D., Warner, J.H., Scahill, R.I., Leavitt, B.R., Stout, J.C., Paulsen, J.S., Reilmann, R., Unschuld, P.G., Wexler, A., Margolis, R.L., Tabrizi, S.J., Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat. Rev. Neurol. 10 (2014), 204–216.
168. Saint Hilaire, M.H., Burke, R.E., Bressman, S.B., Brin, M.F., Fahn, S., Delayed-onset dystonia due to perinatal or early childhood asphyxia. Neurology 41 (1991), 216–222.
169. Saka, E., Goodrich, C., Harlan, P., Madras, B.K., Graybiel, A.M., Repetitive behaviors in monkeys are linked to specific striatal activation patterns. J. Neurosci. 24 (2004), 7557–7565.
170. Saka, E., Iadarola, M., Fitzgerald, D.J., Graybiel, A.M., Local circuit neurons in the striatum regulate neural and behavioral responses to dopaminergic stimulation. Proc. Natl. Acad. Sci. U.S.A. 99 (2002), 9004–9009.
171. Sako, W., Morigaki, R., Kaji, R., Tooyama, I., Okita, S., Kitazato, K., Nagahiro, S., Graybiel, A.M., Goto, S., Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia. Neuroscience 189 (2011), 100–107.
172. Sako, W., Morigaki, R., Nagahiro, S., Kaji, R., Goto, S., Olfactory type G-protein alpha subunit in striosome–matrix dopamine systems in adult mice. Neuroscience 170 (2010), 497–502.
173. Sarnat, H.B., Auer, R.N., Flores-Sarnat, L., Synaptogenesis in the fetal corpus striatum, globus pallidus, and substantia nigra: correlations with striosomes of Graybiel and dyskinesias in premature infants. J. Child Neurol. 28 (2013), 60–69.
174. Sato, K., Sumi-Ichinose, C., Kaji, R., Ikemoto, K., Nomura, T., Nagatsu, I., Ichinose, H., Ito, M., Sako, W., Nagahiro, S., Graybiel, A.M., Goto, S., Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc. Natl. Acad. Sci. U.S.A. 105 (2008), 12551–12556.
175. Schoffelmeer, A.N., De Vries, T.J., Wardeh, G., van de Ven, H.W., Vanderschuren, L.J., Psychostimulant-induced behavioral sensitization depends on nicotinic receptor activation. J. Neurosci. 22 (2002), 3269–3276.
176. Segawa, M., Hereditary progressive dystonia with marked diurnal fluctuation. Brain Dev. 33 (2011), 195–201.
177. Segawa, M., Nomura, Y., Hayashi, M., Dopa-responsive dystonia is caused by particular impairment of nigrostriatal dopamine neurons different from those involved in Parkinson disease: evidence observed in studies on Segawa disease. Neuropediatrics 44 (2013), 61–66.
178. Seredenina, T., Gokce, O., Luthi-Carter, R., Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation. PLoS One, 6, 2011, e22231.
179. Seto-Ohshima, A., Emson, P.C., Lawson, E., Mountjoy, C.Q., Carrasco, L.H., Loss of matrix calcium-binding protein-containing neurons in Huntington's disease. Lancet 1 (1988), 1252–1255.
180. Smith, K.S., Berridge, K.C., Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J. Neurosci. 27 (2007), 1594–1605.
181. Smith, R., Chung, H., Rundquist, S., Maat-Schieman, M.L., Colgan, L., Englund, E., Liu, Y.J., Roos, R.A., Faull, R.L., Brundin, P., Li, J.Y., Cholinergic neuronal defect without cell loss in Huntington's disease. Hum. Mol. Genet. 15 (2006), 3119–3131.
182. Sotak, B.N., Hnasko, T.S., Robinson, S., Kremer, E.J., Palmiter, R.D., Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding. Brain Res. 1061 (2005), 88–96.
183. Steinberger, D., Korinthenberg, R., Topka, H., Berghauser, M., Wedde, R., Muller, U., Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group. Neurology 55 (2000), 1735–1737.
184. Steiner, H., Gerfen, C.R., Dynorphin opioid inhibition of cocaine-induced, D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J. Comp. Neurol. 353 (1995), 200–212.
185. Stevanin, G., Fujigasaki, H., Lebre, A.S., Camuzat, A., Jeannequin, C., Dode, C., Takahashi, J., San, C., Bellance, R., Brice, A., Durr, A., Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126 (2003), 1599–1603.
186. Szczypka, M.S., Kwok, K., Brot, M.D., Marck, B.T., Matsumoto, A.M., Donahue, B.A., Palmiter, R.D., Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice. Neuron 30 (2001), 819–828.
187. Szczypka, M.S., Rainey, M.A., Kim, D.S., Alaynick, W.A., Marck, B.T., Matsumoto, A.M., Palmiter, R.D., Feeding behavior in dopamine-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999), 12138–12143.
188. Tabrizi, S.J., Scahill, R.I., Owen, G., Durr, A., Leavitt, B.R., Roos, R.A., Borowsky, B., Landwehrmeyer, B., Frost, C., Johnson, H., Craufurd, D., Reilmann, R., Stout, J.C., Langbehn, D.R., Investigators, T.-H., Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 12 (2013), 637–649.
189. Tan, A., Moratalla, R., Lyford, G.L., Worley, P., Graybiel, A.M., The activity-regulated cytoskeletal-associated protein arc is expressed in different striosome–matrix patterns following exposure to amphetamine and cocaine. J. Neurochem. 74 (2000), 2074–2078.
190. Tanimura, Y., King, M.A., Williams, D.K., Lewis, M.H., Development of repetitive behavior in a mouse model: roles of indirect and striosomal basal ganglia pathways. Int. J. Dev. Neurosci. 29 (2011), 461–467.
191. Thomsen, M., Conn, P.J., Lindsley, C., Wess, J., Boon, J.Y., Fulton, B.S., Fink-Jensen, A., Caine, S.B., Attenuation of cocaine's reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation. J. Pharmacol. Exp. Ther. 332 (2010), 959–969.
192. Thorn, C.A., Graybiel, A.M., Differential entrainment and learning-related dynamics of spike and local field potential activity in the sensorimotor and associative striatum. J. Neurosci. 34 (2014), 2845–2859.
193. Threlfell, S., Lalic, T., Platt, N.J., Jennings, K.A., Deisseroth, K., Cragg, S.J., Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75 (2012), 58–64.
194. Thu, D.C., Oorschot, D.E., Tippett, L.J., Nana, A.L., Hogg, V.M., Synek, B.J., Luthi-Carter, R., Waldvogel, H.J., Faull, R.L., Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 133 (2010), 1094–1110.
195. Tippett, L.J., Waldvogel, H.J., Thomas, S.J., Hogg, V.M., van Roon-Mom, W., Synek, B.J., Graybiel, A.M., Faull, R.L., Striosomes and mood dysfunction in Huntington's disease. Brain 130 (2007), 206–221.
196. Tokuno, H., Chiken, S., Kametani, K., Moriizumi, T., Efferent projections from the striatal patch compartment: anterograde degeneration after selective ablation of neurons expressing mu-opioid receptor in rats. Neurosci. Lett. 332 (2002), 5–8.
197. Tomasi, D., Volkow, N.D., Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit. Rev. Biochem. Mol. Biol. 48 (2013), 1–19.
198. Tremblay, L., Kemel, M.L., Desban, M., Gauchy, C., Glowinski, J., Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc. Natl. Acad. Sci. U.S.A. 89 (1992), 11214–11218.
199. Unal, C.T., Beverley, J.A., Willuhn, I., Steiner, H., Long-lasting dysregulation of gene expression in corticostriatal circuits after repeated cocaine treatment in adult rats: effects on zif 268 and homer 1a. Eur. J. Neurosci. 29 (2009), 1615–1626.
200. van der Kooy, D., Fishell, G., Neuronal birthdate underlies the development of striatal compartments. Brain Res. 401 (1987), 155–161.
201. Vanderschuren, L.J., Schoffelmeer, A.N., Van Leeuwen, S.D., Hof, L., Jonker, A.J., Voorn, P., Compartment-specific changes in striatal neuronal activity during expression of amphetamine sensitization are the result of drug hypersensitivity. Eur. J. Neurosci. 16 (2002), 2462–2468.
202. Van Laere, K., Casteels, C., Dhollander, I., Goffin, K., Grachev, I., Bormans, G., Vandenberghe, W., Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in vivo. J. Nucl. Med. 51 (2010), 1413–1417.
203. Vemula, S.R., Puschmann, A., Xiao, J., Zhao, Y., Rudzinska, M., Frei, K.P., Truong, D.D., Wszolek, Z.K., LeDoux, M.S., Role of Galpha(olf) in familial and sporadic adult-onset primary dystonia. Hum. Mol. Genet. 22 (2013), 2510–2519.
204. Volkow, N.D., Wang, G.J., Telang, F., Fowler, J.S., Logan, J., Childress, A.R., Jayne, M., Ma, Y., Wong, C., Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J. Neurosci. 26 (2006), 6583–6588.
205. Waldvogel, H.J., Faull, R.L., Compartmentalization of parvalbumin immunoreactivity in the human striatum. Brain Res. 610 (1993), 311–316.
206. Walker, R.H., Arbuthnott, G.W., Baughman, R.W., Graybiel, A.M., Dendritic domains of medium spiny neurons in the primate striatum: relationships to striosomal borders. J. Comp. Neurol. 337 (1993), 614–628.
207. Watabe-Uchida, M., Zhu, L., Ogawa, S.K., Vamanrao, A., Uchida, N., Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74 (2012), 858–873.
208. Wexler, N.S., et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc. Natl. Acad. Sci. U.S.A. 101 (2004), 3498–3503.
209. White, N.M., Hiroi, N., Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum. Proc. Natl. Acad. Sci. U.S.A. 95 (1998), 6486–6491.
210. Wong, S.T., Trinh, K., Hacker, B., Chan, G.C., Lowe, G., Gaggar, A., Xia, Z., Gold, G.H., Storm, D.R., Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice. Neuron 27 (2000), 487–497.
211. Yin, H.H., Mulcare, S.P., Hilario, M.R., Clouse, E., Holloway, T., Davis, M.I., Hansson, A.C., Lovinger, D.M., Costa, R.M., Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat. Neurosci. 12 (2009), 333–341.
212. Yu-Taeger, L., Petrasch-Parwez, E., Osmand, A.P., Redensek, A., Metzger, S., Clemens, L.E., Park, L., Howland, D., Calaminus, C., Gu, X., Pichler, B., Yang, X.W., Riess, O., Nguyen, H.P., A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease. J. Neurosci. 32 (2012), 15426–15438.
213. Zhou, F.M., Liang, Y., Dani, J.A., Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum. Nat. Neurosci. 4 (2001), 1224–1229.